Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Feb 2026 for HERON THERAPEUTICS, INC. /DE/. Read the official filing
Filing timeline
BuySaleAdam Morgan
Insider track record
Disclosed buys
3
Disclosed sells
0
Signal history
Closed purchases
Market purchases
3
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -76.4%Entry US$1.40 · Close at T+365 US$0.33
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Adam Morgan: trading record in brief
Adam Morgan discloses dealings in 2 companies, chiefly Heron Therapeutics, Inc. /DE/ and Alimera Sciences Inc. Over a trading history stretching from 22 February 2023 to 30 January 2026, the count stands at 10 filings.
Every open-market trade on record is a purchase: 3 purchases worth €7.5M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants.
The median purchase comes to €2.3M. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 3 February 2026 with a share grant in Heron Therapeutics, Inc. /DE/. The last insider purchase was made public on 12 August 2025, 432 days ago. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Adam Morgan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
53,960 shares0Common StockSEC:0000921895-26-000200:0
1,766,546 shares@ US$1.5042.6% of flowCommon StockSEC:0000921895-25-002160:0
Canonical exit: 6 Nov 2025 (T+90)
17,950 shares0Common StockSEC:0000950170-25-013780:0
17,950 shares0Common StockSEC:0000950170-25-012043:0
9,429,808 sharesCommon StockSEC:0000921895-24-002133:0
13,948 shares0Common StockSEC:0001209191-24-001980:0
4,845,392 shares@ US$1.7077.5% of flowCommon StockSEC:0000921895-23-002012:0
2,486,744 shares@ US$1.3757.4% of flowCommon Stock, par value $0.01 per shareSEC:0000921895-23-001721:0
Canonical exit: 19 Oct 2023 (T+90)
1,401,901 shares@ US$1.7022.5% of flowCommon StockSEC:0000921895-23-001299:0
Canonical exit: 15 Aug 2023 (T+90)
37,879 shares0Common StockSEC:0001209191-23-012924:0
10 of 10 declarations
